Format

Send to

Choose Destination
See comment in PubMed Commons below
Immune Netw. 2012 Dec;12(6):230-9. doi: 10.4110/in.2012.12.6.230. Epub 2012 Dec 31.

Activation-induced Cytidine Deaminase in B Cell Immunity and Cancers.

Author information

1
Department of Microbiology, College of Medicine, Konyang University, Daejeon 302-718, Korea.

Abstract

Activation-induced cytidine deaminase (AID) is an enzyme that is predominantly expressed in germinal center B cells and plays a pivotal role in immunoglobulin class switch recombination and somatic hypermutation for antibody (Ab) maturation. These two genetic processes endow Abs with protective functions against a multitude of antigens (pathogens) during humoral immune responses. In B cells, AID expression is regulated at the level of either transcriptional activation on AID gene loci or post-transcriptional suppression of AID mRNA. Furthermore, AID stabilization and targeting are determined by post-translational modifications and interactions with other cellular/nuclear factors. On the other hand, aberrant expression of AID causes B cell leukemias and lymphomas, including Burkitt's lymphoma caused by c-myc/IgH translocation. AID is also ectopically expressed in T cells and non-immune cells, and triggers point mutations in relevant DNA loci, resulting in tumorigenesis. Here, I review the recent literatures on the function of AID, regulation of AID expression, stability and targeting in B cells, and AID-related tumor formation.

KEYWORDS:

Activation-induced cytidine deaminase; Antibody; B cell; Cancer

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Korean Association of Immunologists Icon for PubMed Central
    Loading ...
    Support Center